# Kesios Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kesios-therapeutics

- Industry: Pharmaceuticals
- Headquarters: London, UK
- Total disclosed funding: $31M
- Latest round: Series A (Dec 2, 2015)
- Investors on record: 3

## About

Established in 2012, Kesios Therapeutics is based in London, UK and operates as a developer of small molecule drugs for hematological malignancies, such as multiple myeloma and related indications.

## Funding rounds

- Series A, Dec 2, 2015, $28M — Abingworth, SV Health Investors, Touchstone Innovations
- Seed, Oct 8, 2014, $3M — Touchstone Innovations

## Investors

- Touchstone Innovations (https://capitalatlas.ai/funds/touchstone-innovations) — Seed, Series A
- Abingworth (https://capitalatlas.ai/funds/abingworth) — Series A
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series A